Life Science Law Update – Key developments for pharma & device companies in EU and EU Big Five

14 August 2023

- Share by email
- Share on
- Twitter
- LinkedIn
- Get link
- Get QR Code

In this third issue of our Life Science and Health Care Law Update, our teams highlight key trends across life sciences regulatory, corporate, compliance, competition, and privacy throughout the EU, with special focus in this edition on the Big Five (France, Germany, Italy, Spain, UK).

Subscribe to Engage for our quarterly updates on current and evolving European life sciences legal developments – and more.

Do you like what you are reading?

Please log-in or register to access Engage and set your preferences

New to Engage?

Create a free account for access to this publication and our vast catalogue of legal updates

Already Registered?

Log-in to continue reading

Log-in

Keywords Horizon Spotting; Legal Watch; Updates; Pharma, medical device

Languages English

Topics Abuse of Dominance / Unilateral Conduct, Antitrust Investigations, Competition Litigation and Disputes, Competition and Intellectual Property Rights, Sector Inquiries / Market Investigations, Vertical Agreements, Cell, Tissue, and Gene Therapies (CTGT), Clinical Trials, Combination Products, Digital Health, Emerging Companies and Investors, Hospitals and Health Care Providers, Licensing and Commercial Transactions, Life Science Government Enforcement and Compliance, Advertising and Promotion of Pharmaceuticals and Biotechnology, Biologics and Biosimilars, Controlled Substances, Life Cycle Management of Pharmaceuticals and Biotechnology, OTC Drugs and Cosmetics, Regulatory Exclusivities, Hatch-Waxman, and Similar Statutes, Regulatory Inspections and cGMP, Advertising and Promotion of Medical Devices, Clinical Studies/Product Design and Development, Conformity Assessment Procedure/CE Mark, In Vitro Diagnostics, MDR/IVDR, Medical Device Software and Cybersecurity, Postmarket Performance, Premarket Strategy, Submissions, and Review, Coverage and Reimbursement, Drug Pricing and Government Reporting, Health Compliance, Fraud and Abuse, Health Policy and Advocacy, Health Privacy

Countries Belgium, France, Germany, Hungary, Italy, Ireland, Luxembourg, Netherlands, Poland, Spain, United Kingdom

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2022 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.